Filing Details
- Accession Number:
- 0001062993-22-014432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-07 08:14:18
- Reporting Period:
- 2022-06-06
- Accepted Time:
- 2022-06-07 08:14:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1042074 | Cymabay Therapeutics Inc. | CBAY | Pharmaceutical Preparations (2834) | 943103561 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1588861 | Sujal Shah | C/O Cymabay Therapeutics, Inc. 7575 Gateway Blvd., Suite 110 Newark CA 94560 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-06 | 51,301 | $1.95 | 171,301 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
